Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical
Germany has today voted to ban medical cannabis flower from its statutory health insurance scheme, in a controversial move critics
After years of false starts, political delays and administrative paralysis, the United States federal government has taken its first concrete
Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector.
Ananda Pharma, now the leading force in pharmaceutical cannabis research in the UK, has announced that the former Chief Operating
In the intricate landscape of medical cannabis, Belgium has established a regulated framework to govern the use of cannabis for
Jazz Pharmaceuticals Jazz Pharmaceuticals, which has become the world’s largest exporter of medical cannabis products since it bought GW Pharmaceuticals
NEW UK government data suggest that the number of NHS prescriptions for ‘licenced’ cannabis-based medicines could rise significantly this year.
We won’t spam you
